These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 26453486
1. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population. Karatayli-Ozgursoy S, Bishop JA, Hillel A, Akst L, Best SR. Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):235-41. PubMed ID: 26453486 [Abstract] [Full Text] [Related]
2. Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis. Gupta HT, Robinson RA, Murray RC, Karnell LH, Smith RJ, Hoffman HT. Laryngoscope; 2010 Apr; 120(4):698-702. PubMed ID: 20205173 [Abstract] [Full Text] [Related]
3. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature. Gazia F, Galletti B, Freni F, Bruno R, Sireci F, Galletti C, Meduri A, Galletti F. Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003 [Abstract] [Full Text] [Related]
4. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis. Moore JE, Garcia A, Sanyal S, Saunders S, Portnoy JE, Hu A, Sataloff RT. J Voice; 2013 Nov; 27(6):765-8. PubMed ID: 24128893 [Abstract] [Full Text] [Related]
5. Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients. Carvalho CM, Huot L, Charlois AL, Khalfallah SA, Chapuis F, Froehlich P. Acta Otolaryngol; 2009 Apr; 129(4):462-70. PubMed ID: 19235575 [Abstract] [Full Text] [Related]
6. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir. Fusconi M, Grasso M, Greco A, Gallo A, Campo F, Remacle M, Turchetta R, Pagliuca G, DE Vincentiis M. Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828 [Abstract] [Full Text] [Related]
7. Prevalence of dysplasia in juvenile-onset recurrent respiratory papillomatosis. Sajan JA, Kerschner JE, Merati AL, Osipov V, Szabo S, Blumin JH. Arch Otolaryngol Head Neck Surg; 2010 Jan; 136(1):7-11. PubMed ID: 20083770 [Abstract] [Full Text] [Related]
8. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis. Donne AJ, Rothera MP, Homer JJ. Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519 [Abstract] [Full Text] [Related]
9. Efficacy of microsurgery in combined with topical-PDT in treating recurrent respiratory papillomatosis: compare JORRP with AORRP. Yang S, Zhou C, Sun B, Wang F, Han Z, Zhang H, Han J, Shen Y, Zhang J. Acta Otolaryngol; 2019 Dec; 139(12):1133-1139. PubMed ID: 31556770 [Abstract] [Full Text] [Related]
10. Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis. Graupp M, Gugatschka M, Kiesler K, Reckenzaun E, Hammer G, Friedrich G. Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):641-6. PubMed ID: 23070260 [Abstract] [Full Text] [Related]
11. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan. Murono S, Nakanishi Y, Tsuji A, Endo K, Kondo S, Wakisaka N, Yoshizaki T. Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235 [Abstract] [Full Text] [Related]
12. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis. Wierzbicka M, Jackowska J, Bartochowska A, Józefiak A, Szyfter W, Kędzia W. Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834 [Abstract] [Full Text] [Related]
13. Prevalence of human papillomavirus 6 and 11 variants in recurrent respiratory papillomatosis. Sichero L, Ferreira S, López RVM, Mello BP, Costa V, El-Achkar VNR, Carlos R, Ribeiro-Silva A, Pignatari S, Kaminagakura E, Villa LL. J Med Virol; 2021 Jun; 93(6):3835-3840. PubMed ID: 32910471 [Abstract] [Full Text] [Related]
14. The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis. Mikolajczak S, Quante G, Weissenborn S, Wafaisade A, Wieland U, Lüers JC, Klussmann JP, Beutner D. Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2543-8. PubMed ID: 22766836 [Abstract] [Full Text] [Related]
15. Juvenile-onset recurrent respiratory papillomatosis with pulmonary involvement and carcinomatous transformation. Mitsumoto GL, Bernardi FDC, Paes JF, Villa LL, Mello B, Pozzan G. Autops Case Rep; 2018 Dec; 8(3):e2018035. PubMed ID: 30101139 [Abstract] [Full Text] [Related]
16. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature. Shehab N, Sweet BV, Hogikyan ND. Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276 [Abstract] [Full Text] [Related]
17. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression. Go C, Schwartz MR, Donovan DT. Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):298-302. PubMed ID: 12731623 [Abstract] [Full Text] [Related]
18. Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children. Bielecki I, Mniszek J, Cofała M. Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):681-4. PubMed ID: 19193450 [Abstract] [Full Text] [Related]
19. Pulmonary Involvement in Recurrent Respiratory Papillomatosis: A Systematic Review. Sechi I, Muresu N, Di Lorenzo B, Saderi L, Puci M, Aliberti S, Maida I, Mondoni M, Piana A, Sotgiu G. Infect Dis Rep; 2024 Feb 28; 16(2):200-215. PubMed ID: 38525763 [Abstract] [Full Text] [Related]
20. Prevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil. Figueiredo MC, Justino MC, Delmonico L, Silvestre RT, de Castro TL, Dos Santos Moreira A, Macedo JMB, da Costa Carvalho MDG, Scherrer L, de Medeiros Lima DJM, Alves G, Ornellas MH. Auris Nasus Larynx; 2019 Aug 28; 46(4):570-575. PubMed ID: 30581074 [Abstract] [Full Text] [Related] Page: [Next] [New Search]